Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

OncoMed Pharmaceuticals Inc

+ Add to Watchlist

OMED:US

24.9200 USD 0.7200 2.98%

As of 20:10:00 ET on 05/29/2015.

Company Profile for OncoMed Pharmaceuticals Inc (OMED)

OncoMed Pharmaceuticals, Inc. provides biotechnology research and development. The Company synthesizes oncogenic mutations in stem cells that allows the cells to grow without normal limitations in attempts to exploit therapies that selectively target tumor initiating cells. OncoMed Pharmaceuticals serves the healthcare industry and cancer therapy patients in the United States.

Contact Information

OncoMed Pharmaceuticals Inc

800 Chesapeake Drive
Redwood City, CA 94063
United States
Phone: 1-650-995-8200
Fax: 1-650-298-8600

Key Executives for OncoMed Pharmaceuticals Inc (OMED)

Paul J HastingsPresident/CEOJohn A LewickiExec VP/Chief Scientific Ofcr
Sunil PatelSenior VP:Finance/CFOAustin GurneySenior VP:Molecular & Cellular
Timothy Hoey "Tim"Senior VP:Cancer BiologyJakob DupontSenior VP/Chief Medical Ofcr
Alicia J HagerVP/General CounselMichelle CorralSenior Dir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil